At Capnia, we are developing and commercializing innovative diagnostics, devices, and therapeutic products designed to help the smallest patients overcome their biggest obstacles.

Capnia has developed the CoSense® End-Tidal Carbon Monoxide Monitor that measures end-tidal carbon monoxide (ETCO) for the detection of dangerous hemolysis rates. Non-invasive hemolysis detection has important applications for the neonatology market, and newborn care will be an initial commercial focus for the product.

The Infant Solutions product line, including the NeoPIP Infant Resuscitator Unit and accessories, is designed for controlled and accurate resuscitation of neonates and infants in the clinical environment.

Serenz® Allergy Relief is a hand-held device designed to provide rapid relief from symptoms related to allergies. Allergy Relief is ONLY available for commercial sale in select pharmacies in the United Kingdom and Ireland.